Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxazepam, valerian, lavender vs placebo for anxiety and sleep in coronary artery disease
IRCT2016091429822N1Phase 3Completed
- Sponsor
- Vice Chancellor for Research, Birjand University of Medical Sciences
- Start
- Nov 2016
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of oxazepam, valeriana officinalis and lavender oil in coronary arteriosclerosis, anxiety disorder and sleep disorder (4 arms), sponsored by Vice Chancellor for Research, Birjand University of Medical Sciences. Primary endpoints: Anxiety level and Sleep quality. Started Nov 2016; status: completed.
02
Drugs
oxazepamvaleriana officinalislavender oil
03
Conditions
coronary arteriosclerosisanxiety disordersleep disorder
Beyond the preview
Go deeper on IRCT2016091429822N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2016091429822N1.